Metformin attenuates cuprizone-induced mitochondrial dysfunction and senescence-associated changes in primary neuronal cells
Cell Structure and Function · 2026 · 51 (1) · 215-226
DOI: 10.1247/csf.26019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Structure and Function, 2026. Verfasst von Yeojin Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Neural Circuit Research Group, Korea Brain Research Institute. Hauptthemen laut MEDLINE: Neurons, Mitochondria, Metformin, Cellular Senescence. Die Arbeit nennt 39 Literaturangaben.
Abstract (Originalsprache)
Mitochondrial dysfunction and cellular senescence are key features of brain aging and neurodegenerative diseases. Cuprizone (CPZ), a mitochondrial toxin, induces oxidative stress, abnormal lipid metabolism, and iron accumulation in neurons and oligodendrocytes. Here, we investigated whether metformin (MFN), an AMPK activator with a known safety profile, can protect against CPZ-induced mitochondrial and senescence-like changes. Using confocal and transmission electron microscopy, we observed mitochondrial enlargement, increased reactive oxygen species (ROS) production, iron accumulation, and lipofuscin formation in CPZ-treated primary neuronal cultures. Next, we assessed the impact of MFN on mitochondrial changes and increase in lipid-radicals in cells exposed to CPZ. The treatment of MFN resulted in decreased abnormal mega-mitochondrial morphology, decreased levels of mitochondrial reactive oxygen species (mitoROS), and decreased iron accumulation within mitochondria. Moreover, MFN treatment prevented the typically observed increases in lipofuscin and lipid radicals in CPZ-affected cells. Analysis of gene expression in primary neuronal cells treated with CPZ showed differences in mitochondria-related genes linked to lipid peroxidation, oxidative stress, and cellular senescence. These findings suggest that MFN mitigates mitochondrial dysfunction and senescence-associated alterations, highlighting its therapeutic potential in aging-related neurodegeneration.Key words: mitochondria, CPZ, MFN, oxidative stress, lipofuscin
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neural Circuit Research Group, Korea Brain Research Institute.
- Division of Chemical Engineering and Bioengineering, College of Art, Culture and Engineering, Kangwon National University.
- Multidimensional Genomics Research Center, Kangwon National University.
Zitieren
APA
Kim, Y., Jeon, H., Gwon, S. Y., Chae, S., & Mun, J. Y. (2026). Metformin attenuates cuprizone-induced mitochondrial dysfunction and senescence-associated changes in primary neuronal cells. Cell Structure and Function, 51(1), 215-226. https://doi.org/10.1247/csf.26019
Vancouver
Kim Y, Jeon H, Gwon SY, Chae S, Mun JY. Metformin attenuates cuprizone-induced mitochondrial dysfunction and senescence-associated changes in primary neuronal cells. Cell Structure and Function. 2026;51(1):215-226. doi:10.1247/csf.26019
BibTeX
@article{Kim2026,
author = {Kim, Yeojin and Jeon, Hyunbum and Gwon, Sun-Yeong and Chae, Sehyun and Mun, Ji Young},
title = {Metformin attenuates cuprizone-induced mitochondrial dysfunction and senescence-associated changes in primary neuronal cells},
journal = {Cell Structure and Function},
year = {2026},
volume = {51},
number = {1},
pages = {215--226},
doi = {10.1247/csf.26019}
}
EUVIMED